Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

GSK’s over-the-counter nicotine oral spray gets FDA panel backing

An independent expert panel to the U.S. FDA recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.

Read More »

India bans e-cigarettes as global backlash at vaping gathers pace

India banned the sale of electronic cigarettes and warned of an “epidemic” among young people, in the latest and potentially biggest move globally against vaping over growing health concerns.

Read More »

Trump administration seeks ban on flavored e-cigarettes to combat youth addiction

The Trump administration announced plans to remove all flavored e-cigarettes from store shelves in a widening crackdown on vaping, as officials warned that sweet flavors had drawn millions of children into nicotine addiction.

Read More »

Mallinckrodt taps restructuring firms: Bloomberg

Mallinckrodt Plc hired restructuring firms and may choose to seek bankruptcy protection, Bloomberg reported, sending the drugmaker’s shares down 40 percent.

Read More »

J&J liable in Oklahoma opioid epidemic trial

An Oklahoma judge ordered Johnson & Johnson to pay $572.1 million to the state for the company’s part in fueling an opioid epidemic by deceptively marketing addictive painkillers, a sum substantially less than investors expected, driving up J&J shares.

Read More »

New Insights Could Lead to More Control Over Opioid Addiction

Researchers at The Scripps Research Institute in Florida published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.

Read More »

U.S. FDA proposes new health warnings on cigarette packs, advertisements

The FDA proposed new health warnings for cigarette packages and ads due to small size and lack of an image in current warnings.

Read More »

Indivior loses appeal to block generic Suboxone opioid treatments

A divided federal appeals court ruled against Indivior’s bid to stop Dr. Reddy’s Laboratories and Alvogen from selling generic versions of the London-based company’s Suboxone film that infringed the opioid addiction treatment’s patents.

Read More »

Reckitt Benckiser Settles Indivior Opioid Investigation

Reckitt Benckiser Group agreed to pay $1.4 billion to settle a U.S. investigation into the sales and marketing of Suboxone Film, a product managed by the spinout company Indivior.

Read More »

FDA Issues Warnings to Companies Illegally Selling Drugs Containing Kratom

The FDA issued warning letters to two companies for illegally selling unapproved drug products that contain the herbal extract kratom.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom